Since KISS1R signaling is now implicated in the promotion of metastasis and drug resistance, two major factors leading to poor breast cancer patient prognosis, it may be an attractive drug target for the development of therapeutics to improve treatment of TNBC patients. Here, KISS1R is linked to breast carcinoma.